Inhaltsseite: Home

ZKB Mini-Future Long auf Novo Nordisk -B-, Open End
Novo Nordisk A/S

ISIN: CH1305137833 Security: 130513783 Symbol: INOOVZ Life cycle
redeemed

Bid Price n.a.

Ask Price n.a.

Currency n.a.

Exchange SIX Structured Products

Volume n.a.

Volume n.a.

Date/time (delayed) n.a. n.a.

Sell Buy 

Product Download

Security PDF for download Publication date
Termsheet 05.08.2024
Key Information Document DE 05.08.2024
Key Information Document EN 05.08.2024
Key Information Document FR 05.08.2024
Key Information Document IT 05.08.2024

Price data

  Bid Ask
Price n.a. n.a.
Volume n.a. n.a.
Date/time n.a. n.a. n.a. n.a.

Current data

Last price paid n.a.
Change -9.68% [ -0.03 ]
Last traded volume n.a. Unit
Cumulative volume n.a. Unit
Date/time n.a. n.a.

Life cycle

Fixingn.a.
Settlement date21.02.2024
Last tradingn.a.
Final fixingn.a.
Currency redemptionCHF

Performance

Perf. since issue +78.26%
Year to date (YTD) n.a.
1 month -48.15%
3 months +7.69%
1 year n.a.
3 years n.a.

Key figures on issue

Issue price0.23
Underlying price on issue857.40
Premium0.08%
Premium p.a.n.a.
Leveragen.a.
Implied volatilityn.a.

Reference data

ISIN CH1305137833
Symbol INOOVZ
Security 130513783
Exchange SIX Structured Products
Currency CHF
Expiry n.a.
Underlying Novo Nordisk -B-, DK0062498333
Underlying ISIN DK0062498333
Funding level 793.723600
Stop-loss level 824.960600
Distance to stop-loss level 7.10%
Long/Short type Long
Subscription ratio 50.00
Issuer Zürcher Kantonalbank
Exercise type n.a.
Minimum execution n.a.
Value day 19.02.2024

Key figures

Premium 7.87%
Premium p.a. n.a.
Leverage 5.41
Moneyness in-the-money
Leverage n.a.
Delta n.a.
Intrinsic value 94.276400
Break-even n.a.
SSPA value at risk n.a.
SSPA risk rating n.a.

Product type

SSPA derivative category Leverage
SSPA code Mini future (2210)

Early redemption

Redemption date 12.08.2024
Redemption amount 0.0775

Ajax loading